Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
HYMPAVZI Inj Lös 150 mg/ml Fertpen 1 ml
Drug
Hympavzi, Injektionslösung im Fertigpen
Schwere Hämophilie A ohne Inhibitoren und schwere Hämophilie B ohne Inhibitoren
06.01.1. – units of blood and plasmafractions
HAM – Human medicine
INLFP – Solution for injection in pre-filled pen
BT – biological medicines
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
12/23/2024
12/22/2029
Dosage strength
Hympavzi 150 mg, Injektionslösung im Fertigpen
Schwere Hämophilie A ohne Inhibitoren und schwere Hämophilie B ohne Inhibitoren
01
Z – approved
Package
7680695560015
In trade from / since 12/23/2024
A/R – Authorised / referenced
1 piece(s)
001
Z – approved
Declaration
Component
150 mg marstacimabum
histidinum
histidini hydrochloridum monohydricum
saccharum
dinatrii edetas
polysorbatum 80
aqua ad iniectabile
0.0062 mg natrium
histidini hydrochloridum monohydricum
saccharum
dinatrii edetas
polysorbatum 80
aqua ad iniectabile
0.0062 mg natrium
Spezialitätenliste***
GGSL
-
-
6884.10
None
Yes
10%
No
Authorisation holder
7601001010604
Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)
Schärenmoosstrasse 99
8052 Zürich (ZH)
Date of revision of the text
7/4/2025
Please log in as a company employee using your SIMIS-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.